(Q33273821)

25 July 2017

title

MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusions (English)

1 reference

25 July 2017

0 references

1 reference

Florian Grabellus

1

1 reference

25 July 2017

Margarethe J Konik

2

1 reference

25 July 2017

Karl Worm

3

1 reference

25 July 2017

Sien-Yi Sheu

4

1 reference

25 July 2017

Johannes A P van de Nes

5

1 reference

25 July 2017

Sebastian Bauer

6

1 reference

25 July 2017

Werner Paulus

7

1 reference

25 July 2017

Rupert Egensperger

8

1 reference

25 July 2017

Kurt W Schmid

9

1 reference

25 July 2017

publication date

6 March 2010

1 reference

25 July 2017

1 reference

25 July 2017

volume

31

1 reference

25 July 2017

issue

3

1 reference

25 July 2017

page(s)

157-163

1 reference

Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0021-0

Dysregulation of Met receptor tyrosine kinase activity in invasive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0021-0

Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0021-0

Effect of bone decalcification procedures on DNA in situ hybridization and comparative genomic hybridization. EDTA is highly preferable to a routinely used acid decalcifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-010-0021-0

Emerging role of proton beam radiation therapy for chordoma and chondrosarcoma of the skull base

21 January 2018

1 reference

12 December 2020

Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase

1 reference

12 December 2020

The influence of polysomy 17 on HER2 gene and protein expression in adenocarcinoma of the breast: a fluorescent in situ hybridization, immunohistochemical, and isotopic mRNA in situ hybridization study

1 reference

12 December 2020

Operative management of sacral chordoma

1 reference

12 December 2020

Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma

1 reference

12 December 2020

Imatinib mesylate in chordoma

1 reference

12 December 2020

Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.

1 reference

12 December 2020

Drug development of MET inhibitors: targeting oncogene addiction and expedience

1 reference

12 December 2020

Expression of hepatocyte growth factor and c-MET in skull base chordoma

1 reference

12 December 2020

Novel therapeutic inhibitors of the c-Met signaling pathway in cancer

1 reference

12 December 2020

MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data

1 reference

12 December 2020

TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition

1 reference

12 December 2020

Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer

1 reference

12 December 2020

Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.

1 reference

12 December 2020

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization

1 reference

12 December 2020

The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas

1 reference

12 December 2020

Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients

1 reference

12 December 2020

[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]

1 reference

12 December 2020

c-Met: structure, functions and potential for therapeutic inhibition

1 reference

12 December 2020

Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status

1 reference

12 December 2020

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

1 reference

12 December 2020

Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases

1 reference

12 December 2020

Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas

1 reference

12 December 2020

Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice

1 reference

12 December 2020

Met decoys: will cancer take the bait?

1 reference

12 December 2020

Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma

1 reference

12 December 2020

Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma

1 reference

12 December 2020

The MET receptor tyrosine kinase in invasion and metastasis

1 reference

12 December 2020

A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo

1 reference

12 December 2020

Gene translocations in musculoskeletal neoplasms

1 reference

12 December 2020

Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma

1 reference

12 December 2020

Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling

1 reference

12 December 2020

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma

1 reference

12 December 2020

Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies

1 reference

12 December 2020

Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry

1 reference

12 December 2020

Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling.

1 reference

12 December 2020

Chromosome 7 abnormalities are common in chordomas

1 reference

12 December 2020

10.1007/S13277-010-0021-0

Identifiers

DOI

1 reference

Dimensions Publication ID

25 July 2017

1015892164

0 references

1 reference